Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease

被引:54
作者
Akinyoola, A. L. [1 ]
Adediran, I. A. [2 ]
Asaleye, C. M. [3 ]
Bolarinwa, A. R. [2 ]
机构
[1] Obafemi Awolowo Univ, Dept Orthopaed Surg & Traumatol, Ife, Nigeria
[2] Obafemi Awolowo Univ, Dept Haematol & Blood Transfus, Ife, Nigeria
[3] Obafemi Awolowo Univ, Dept Radiol, Ife, Nigeria
关键词
AVASCULAR NECROSIS; FIBRINOLYTIC-ACTIVITY; ANTITHROMBIN; COAGULATION; ADULTS;
D O I
10.1007/s00264-008-0584-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7 +/- 4.9 years) had a significantly higher rate of painful crises (p = 0.03) and hospitalisations per year (p = 0.002) than the group without avascular necrosis (mean age 21.6 +/- 5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (p = 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial.
引用
收藏
页码:923 / 926
页数:4
相关论文
共 21 条
[1]
Avascular necrosis of the hip in children with sickle cell disease and high Hb F:: Magnetic resonance imaging findings and influence of α-thalassemia trait [J].
Adekile, AD ;
Gupta, R ;
Yacoub, F ;
Sinan, T ;
Al-Bloushi, M ;
Haider, MZ .
ACTA HAEMATOLOGICA, 2001, 105 (01) :27-31
[2]
Akinyoola A L, 2007, Niger Postgrad Med J, V14, P217
[3]
Aluoch JR, 1998, E AFR MED J, V75, P351
[4]
Bain BJ, 1995, PRACTICAL HAEMATOLOG, P37
[5]
Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state [J].
Bayazit, AK ;
Kilinç, Y .
PEDIATRICS INTERNATIONAL, 2001, 43 (06) :592-596
[6]
Plasma fibrinogen levels in Nigerian homozygous (Hb SS) sickle cell patients [J].
Buseri, Fiekumo I. ;
Shokunbi, Wuraola A. ;
Jeremiah, Zaccheaus A. .
HEMOGLOBIN, 2007, 31 (01) :89-92
[7]
DACIE JV, 1995, PRACTICAL HAEMATOLOG, P75
[8]
FAMODU AA, 1988, TROP GEOGR MED, V40, P331
[9]
HAWKER H, 1982, BRIT J HAEMATOL, V50, P29
[10]
The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease [J].
Hernigou, Ph. ;
Habibi, A. ;
Bachir, D. ;
Galacteros, F. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2006, 88A (12) :2565-2572